Compass Therapeutics, Inc. (CMPX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Compass Therapeutics, Inc. (CMPX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CMPX Income Statement

Compass Therapeutics, Inc. (CMPX) annual income statement — 8-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	850K	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	368K	370K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-368K	-370K	0	0	0	0	0	850K	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	100%	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	26.98M	19.93M	17.62M	15.82M	21.07M	17.97M	16.57M	12.24M	15.89M	12.77M	15.39M	11.93M	13.34M	9.71M	12.89M	12.6M	8.99M	7.18M	13M	5.85M
OpEx % of Revenue	-	-	-	-	-	-	-	-	1870%	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	7.4M	6.56M	4.32M	2.99M	4.65M	4.91M	3.54M	3.63M	4.72M	3.25M	2.97M	3.1M	3.11M	3.07M	2.96M	2.81M	3.13M	2.77M	3.43M	2.7M
SG&A % of Revenue	-	-	-	-	-	-	-	-	555.41%	-	-	-	-	-	-	-	-	-	-	-
Research & Development	19.58M	13.38M	13.67M	12.83M	16.41M	13.05M	13.04M	8.61M	11.17M	9.52M	12.43M	8.83M	10.22M	6.64M	9.93M	9.79M	5.86M	4.42M	9.57M	3.15M
R&D % of Revenue	-	-	-	-	-	-	-	-	1314.59%	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	-370K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-26.98M	-20.3M	-17.99M	-15.82M	-21.07M	-17.97M	-16.57M	-12.24M	-15.04M	-12.77M	-15.39M	-11.93M	-13.34M	-9.71M	-12.89M	-12.6M	-8.99M	-7.18M	-13M	-5.85M
Operating Margin %	-	-	-	-	-	-	-	-	-1770%	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-28.07%	-12.99%	-8.54%	-29.23%	-40.02%	-40.69%	-7.67%	-2.62%	-12.81%	-31.5%	-19.44%	5.33%	-48.4%	-35.21%	0.87%	-115.2%	83.86%	2.14%	-63.53%	34.67%
EBITDA	-26.96M	-19.93M	-17.62M	-15.8M	-20.7M	-17.6M	-16.21M	-11.77M	-14.58M	-12.31M	-15.23M	-11.46M	-12.86M	-9.23M	-12.4M	-12.11M	-8.49M	-6.75M	-12.61M	-5.45M
EBITDA Margin %	-	-	-	-	-	-	-	-	-1715.18%	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-30.24%	-13.23%	-8.66%	-34.18%	-41.98%	-43.02%	-6.45%	-2.74%	-13.35%	-33.34%	-22.8%	5.38%	-51.51%	-36.8%	1.59%	-122.3%	84.64%	2.58%	-83.19%	36.1%
D&A (Non-Cash Add-back)	21K	368K	370K	19K	367K	364K	359K	465K	466K	463K	161K	466K	475K	481K	484K	487K	498K	435K	396K	406K
EBIT	-25.15M	-18.32M	-15.72M	-14.26M	-19.88M	-16.63M	-15.03M	-10.48M	-13.08M	-10.79M	-15.39M	-11.93M	-13.34M	-9.71M	-11.59M	-12.6M	-8.99M	-7.18M	-12.96M	-5.9M
Net Interest Income	1.82M	1.98M	2.27M	1.56M	1.19M	1.33M	1.59M	1.76M	1.97M	1.98M	1.98M	1.96M	2.06M	0	0	0	0	0	-35K	-77K
Interest Income	1.82M	1.98M	2.27M	1.56M	1.19M	1.33M	1.59M	1.76M	1.97M	1.98M	1.98M	1.96M	2.06M	0	1.29M	623K	424K	20K	4K	1K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.29M	623K	424K	20K	39K	78K
Other Income/Expense	1.82M	1.98M	2.27M	1.56M	1.19M	1.33M	1.54M	1.76M	1.97M	1.98M	1.98M	1.96M	2.06M	1.87M	1.29M	623K	493K	20K	7K	-121K
Pretax Income	-25.15M	-18.32M	-15.72M	-14.26M	-19.88M	-16.63M	-15.03M	-10.48M	-13.08M	-10.79M	-13.41M	-9.96M	-11.28M	-7.84M	-11.59M	-11.97M	-8.49M	-7.16M	-12.99M	-5.97M
Pretax Margin %	-	-	-	-	-	-	-	-	-1538.35%	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-13K	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0.1%	0%
Net Income	-25.15M	-18.32M	-15.72M	-14.26M	-19.88M	-16.63M	-15.03M	-10.48M	-13.08M	-10.79M	-13.41M	-9.96M	-11.28M	-7.84M	-11.59M	-11.97M	-8.49M	-7.16M	-12.98M	-5.97M
Net Margin %	-	-	-	-	-	-	-	-	-1538.35%	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-26.52%	-10.12%	-4.54%	-36.05%	-52.04%	-54.19%	-12.06%	-5.19%	-15.94%	-37.64%	-15.71%	16.79%	-32.78%	-9.42%	10.68%	-100.42%	84.78%	3.5%	-54.7%	34.7%
Net Income (Continuing)	-25.15M	-18.32M	-15.72M	-14.26M	-19.88M	-16.63M	-15.03M	-10.48M	-13.08M	-10.79M	-13.41M	-9.96M	-11.28M	-7.84M	-11.59M	-11.97M	-8.49M	-7.16M	-12.98M	-5.97M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.13	-0.10	-0.09	-0.10	-0.14	-0.12	-0.11	-0.08	-0.10	-0.08	-0.11	-0.08	-0.09	-0.05	-0.10	-0.11	-0.08	-0.07	-0.25	-0.10
EPS Growth %	7.14%	16.67%	22.73%	-31.23%	-47.37%	-50%	0%	4.75%	-5.56%	-69.49%	-12.36%	27.27%	-13.49%	33.33%	60.84%	-10%	92.59%	49.43%	-78.57%	33.33%
EPS (Basic)	-0.13	-0.10	-0.09	-0.10	-0.14	-0.12	-0.11	-0.08	-0.10	-0.08	-0.11	-0.08	-0.09	-0.05	-0.10	-0.11	-0.08	-0.07	-0.25	-0.10
Diluted Shares Outstanding	186.8M	186.4M	184.84M	138.28M	138.28M	138.24M	136.63M	137.59M	137.59M	136.61M	127.67M	127.42M	126.73M	126.38M	105.19M	101.01M	100.95M	100.86M	51.91M	61.69M
Basic Shares Outstanding	186.8M	186.4M	184.84M	138.28M	138.28M	138.24M	136.63M	137.59M	137.59M	136.61M	127.67M	127.42M	126.73M	126.38M	105.19M	101.01M	100.95M	100.86M	51.91M	61.69M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-